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The Parkinson’s disease (PD) is a neurodegenerative movement disorder that affect more
than 30 million persons around the world. This disease is evidenced by control movement
alterations such as rigidity, tremor, bradykinesia and balance impairments, that results of
the deficit of dopamine neurotransmitter. Classically, the clinical PD diagnosis comes from
the evaluation and quantification of motion pattern alterations that allows to establish dif-
ferent levels of the disease. Such evaluation is however focus in the analysis upper and lower
limbs movements, which may be insensitive at the first stages of the disease. Currently,
several studies have show that a strong correlation between the eye motion alterations and
the dopamine deficiency, being these motion pattern highly sensitives to changes in concen-
tration levels of this neurotransmitter, even in early stages of the disease. However, clinical
eye motion studies use specific protocols and devices that restrict the analysis to static envi-
ronments with strong controlled scenarios. Additionally, much of the devices used to register
the eye motion patterns are invasive and they can alter the ocular dynamic. In this work
is introduced a novel strategy to capture the ocular motion during gait by using a external
camera that track the eye motions from a free displacement of the patient. Furthermore,
two strategies were proposed to analyze the dynamic patterns: 1) a global strategy that
follow the eye trajectory during the patient displacement and 2) a local strategy that codify
the distribution of instantaneous motion orientations. Both strategies were evaluated in real
scenarios with PD patients at different levels of the disease, showing important differences
among them, even in patients in early stages of the disease.




La Enfermedad de Parkinson (EP) es un trastorno de movimiento que afecta a más de
30 millones de personas alrededor del mundo. Esta enfermedad se evidencia en alteraciones
de movimiento como rigidez, temblor, bradicinesia y deterioro del balance, como resultado
del déficit del neurotransmisor dopamina. Tradicionalmente, el diagnóstico cĺınico de la PD
proviene de la evaluación y cuantificación de los patrones de movimientos alterados que per-
miten establecer diferentes niveles o estadios de la enfermedad. Esta evaluación sin embargo
se centra en el análisis de los movimientos de los miembros inferiores y superiores, los cuales
pueden ser poco sensibles en los primeros estadios de la enfermedad. Actualmente, muchos
estudios han mostrado una fuerte correlación entre las alteraciones del movimiento del ojo y
la deficiencia de la dopamina, ya que este patrón de movimiento es altamente sensible a los
cambios en los niveles de concentración de este neurotransmisor, aun en estadios tempranos
de esta enfermedad. Sin embargo, el estudio cĺınico de los movimientos del ojo requiere pro-
tocolos espećıficos y dispositivos que restringen el análisis a entornos estáticos con escenarios
fuertemente controlados. Adicionalmente, muchos de los dispositivos usados para registrar
los patrones del movimiento del ojo son invasivos y pueden alterar la dinámica ocular. En
este trabajo se introduce una novedosa estrategia para capturar el movimiento ocular du-
rante la marcha por medio del uso de una cámara externa que sigue el movimiento de los ojos
desde un libre desplazamiento del paciente. De igual forma, dos estrategias fueron propuestas
para analizar la dinámica de estos patrones: 1) una estrategia global que sigue la trayectoria
del ojo durante la marcha del paciente y 2) una estrategia que codifica la distribución de
la orientación instantánea de las orientaciones de movimiento. Estas dos estrategias fueron
evaluadas en escenarios reales con pacientes con EP con diferentes niveles de la enfermedad,
mostrando importantes diferencias entre ellos, aun en pacientes en estadios tempranos de la
enfermedad.
Palabras claves: Enfermedad de Parkinson, Movimiento del ojo, análisis de mar-
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1 Theoretical Framework
1.1 Introduction
The PD is one of the most prevalent neuro-degenerative diseases around the world [45],
affecting around 30 million people [52], and with an expectation of the double of reported
cases in the next 15 years [40, 35, 50, 34]. This disease is related with motor system disorders
caused by the deficit of the dopamine neurotransmitter. Such deficit generates in long and
mid term affections related with movement regulation and velocity [10, 46]. Specifically,
the progressive loss of dopamine introduce several problems, as: a communication failure
between the cortical area and the musculo-skeletal system, degeneration in general of the
neural network and imbalance between inhibition/activation of neuronal commands [38, 46]
(see in Figure 1-1).
Those alterations, expressed as a set of movement disorders, progressively exacerbated in
time, are currently used to coarsely quantify the disease. Such symptoms are mainly de-
scribed as: (1) Bradykinesia (slow movement), (2) resting tremor, (3) rigidity and (4) im-
paired balance [13, 19]. In the clinical domain, the most commonly test used to diagnose
the PD is the “UK Parkinson’s Disease Society Brain Bank Clinical Diagnostic Criteria”
(UKPDSBRC). This test is based on two main factors: 1) the evaluation and quantification
of motor symptoms and 2) the evaluation of the patient response to dopaminergic medication
[32, 17]. Complementary, the “Hoehn and Yahr scale” [25], classify the progression of the
disease in five stages, following those motor descriptions, such as [25]:
Stage 1: associated to patients with early motor alterations such as mild unilateral rigidity,
tremor or slowness of movement. At this stage, there exist a large number of false-
positive reports caused by the poor occurrence and the small amplitude of motor
alterations patterns, that can lead to wrong evaluations.
Stage 2: related with the “midline” or axial affectation, exposes the increasing of early
symptoms, combined with trunk instability and the presence of motor symptoms in
the non-affected body side. During this phase, there are not also evidence of impaired
balance, whereby in most of cases there are not a PD diagnosis.
Stage 3: includes the first signs of impaired balance and retropulsion test failures that
difficult to the patients to maintain an upright posture facing an external stimulus.
Also, there exist a subtle loss of independence which may be imperceptible.
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Stage 4: is characterized by the significantly impaired of the patients, with strong ev-
idence of the disease w.r.t. the motor patterns. In this phase the patients report
strong difficulty to maintain a bipedal position and to develop the locomotion without
assistance.
Stage 5: described in patients with fully lost of mobility. In much of the cases the limitation
of the patient independence is exacerbated to activities like eating by itself or turning
in bed.
The description of such scale is very important to the proper following and intervention of
the patient. However, despite of the efforts developed to quantify and classify the PD, this
proposed scale result very coarse among the stages and there are not a precise description
of the symptoms. Hence, in much of the PD cases, the diagnosis and following is fuzzy or
even ambiguous to take clinical decisions [25]. Some researches have revealed the dramatic
problem related with PD diagnosis, for instance, the accuracy in PD diagnosis has been
evaluated in [47] with 5260 patients, obtaining 82.7% w.r.t the precision in the diagnosis
by experts. Even worse, when the diagnosis was performed by physical doctor with no so
much expertise in movement disorders, the results were 76.2% and 76.4% respectively. Other
studies reported a specificity between 0.42% to 0.77% in PD diagnosis [27]. Those results
have evidenced a salient misclassification and low accuracy in the diagnosis, which could
be critical in early stages, where namely there are less clues and evidences to determine
the disease progression. Additional technical tools have been introduced to support the
diagnosis and reduce the high variability and low specificity intra experts. Among the most
important, the gait analysis allows to compute several kinetic and kinematic patterns which
are correlated with different stages of the disease [7, 59, 47].
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Figure 1-1: The regulation movement system could be represented as closed-loop control
system. The input is the stimulus movement from upper zones of the brain.
This signal is controlled by the basal ganglia, regulating the movement by
a feedback component, the dopamine as the main neurotrasmitter. The loss
regulation of these stimulus generated disturbances in movement typically in
PD.
In general terms, the gait is an important marker of the PD diseases because such phe-
nomenon, under normal conditions, requires the integrity and interaction of different control
and movement subsystems to achieve an optimal energy consumption[49, 64]. Neverthe-
less, the parkinsonian gait is characterized by the velocity reduction, short stride length
decreasing, abnormal postures to maintain the control, among others [48, 20].
The gait analysis is namely developed in a controlled conditions, where a set of devices
allow to capture different kinematic and kinetic relationships which together with energy
consumption indicator can be useful to support the progression of the disease. Also, this
quantitative evaluation allows to reduce the subjectivity and identify differences among
musculoskeletal or neuromuscular disorders. The advantage of these tools, as support in
the diagnosis and following of the disease, has been widely tested in clinical scenarios by
physicians with different levels of expertise. In spite of the advantages of the gait analysis,
there exist main concerns with respect to the PD described as follows [53, 64]:
• The gait patterns are revealed in patients with advanced level of the disease (stages 3
and 4), being one of the main limitations the sensibility to recognize subtle changes in
early stages.
• The controlled conditions and the invasive nature of some of the devices used limit
the motor evaluation of the patients and many times alters the natural gesture of the
motion.
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• The clinical report of the gait analysis namely result from the correlation between
the patient patterns with patterns computed from a control population. However, the
alteration of PD patients have high variability in any of the stages, and the statistical
comparison many times result insufficient [5, 48, 37].
• the “limb motor symptoms” or classical symptoms to diagnose PD appear after the
loss of 50% of dopamine-producing cells, responsible to movement control [16], which
result dramatic to propose a early treatment.
All of these limitations have motivated to the exploration of new biomarkers to improve
the diagnosis and following [52], with special pay attention in early stages of the disease.
Recently, some works have described that the eye movement alterations can be used as an
alternative and powerful biomarker in PD and in other neurodegenerative disorders [3].In
fact, the ocular movement requires a refined neural control which directly leads to high
sensible to slight changes in dopamine levels [43, 26]. From these experiences have been
shown that the eye movement alteration can suggest a “pre-motor” phase (before a significant
neurodegeneration) of the disease[51, 65].
The reliable performance of eye movement as biomarker in PD, was described in the seminal
work proposed by Gitchel, et al in 2012 [24], in which was found that the 100% of patients
with PD in different stages presented eye alterations. In addition, the study found that
visual alteration in a subject who has not yet been diagnosed with PD, and developing the
disease eventually [24]. Many studies described [4], that the eye movement alterations are
represented as changes in ocular control, specially in direction and velocity [28] (see in Figure
1-2). Nonetheless, the proper computation of eye motion is challenge since many times the
abnormal ocular behaviors can be wrapped with the head tremor that may be present in
PD [33]. Therefore, a proper methodology to evaluate eye motion patterns evolution under
isolated conditions in which the head motion can be filtered out remains as an open question
[6].
Eye abnormalities are usually assess in passive or artificial tasks[33] that consist in the
tracking of an object by the eye. In this case, the eye motion can be forced to follow normal
patterns, leading to a wrong diagnosis. Additionally test are based on the electrooculography
analysis, which is focus only in the plane of eye movements [22], losing the other visual field
components. Moreover, this kind of device have some problems in the capture because the
electrical signal of the eye muscle is weak [11, 54] and can be contaminated by noise.
Currently, there are some studies that try to capture eye motion patterns in free scenarios,
under the assumption that eye abnormalities are amplified during a natural movement pat-
tern, as the human gait [2], as is illustrated in Figure 1-3. In this specific case, the eye has
the main role of explore and sense the environment around during the gait, to establish the
best dynamical configuration of limbs to develop an optimal movement [62, 55, 41]. Some
seminal works show the relevance of capture the eye motion during the locomotion to detect
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Figure 1-2: The comparison of ocular movement between control and PD patient. In the
left panel (a) show the suitable perception of environment or an object when
the eye movement control is appropriate. And in the right panel (b), show
the ocular movement deficiency and the alteration of the image perception,
affecting the movement performance in gait, commonly in PD
early patterns that can be related with the PD. Some of the limitations of such works is the
use of invasive electrooculography devices [2, 41].
In this thesis is introduced a novel methodology to analyze the eye motion in free locomotion
activities by characterizing ocular patterns registered in video sequences. Such patterns were
evaluated under different conditions and with a population of PD patients, diagnoses at
different levels of the disease. For doing so, the patient was equipped with a helmet camera
that recorded high-speed sequences with the ocular motion, while the patient developed the
locomotion. Then, a first proposal evaluates the global ocular dynamic trend by following
the eye trajectory in time. For doing so, a adaptive boosting algorithm was trained with raw
geometrical and appearance eye features. The computation of such eye trajectories show
differences between control subject and PD patients, being a promising biomarker to detect
patterns associated to early PD stages. A second proposed method was aimed to explore
more local detailed patterns of the eye motion, present during the locomotion. To this end, a
set of orientation histogram distributions were established from the computation of a dense
optical flow computed in each video sequence of the recorded ocular motion. In this case, was
found more descriptive eye motion patterns that can be useful to support the early diagnosis
of PD, and also report a substantial difference in the different stages of the disease, even
when the gait movements are close to control patterns.
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Figure 1-3: The comparison of two evaluation strategies for ocular movement in a subject
with PD. In a), this method consist in moves the head’s patient in a sitting
position by the evaluator, observing any abnormality in the eye movement.
However, in advanced levels of the pathology, the alterations are not easily
noticeable. In contrast, b) this subject during gait pattern, the alterations
are exposed with highly amplitude movement. In this condition, the ocular




Parkinson’s disease is not objectively evaluated.
– Research Question:
How to quantitatively support the diagnosis, the follow-up and the treatment of
any stage of the disease?
• Objectives
– Main Goal
∗ To quantitatively characterize the eye motion during gait to support the PD
diagnosis and classification.
– Specific Objectives
∗ To build a dataset of eye movement for PD and control patients during gait.
∗ To develop a strategy that characterizes the eye movements during gait.
∗ To classify subjects with PD by stages based on eye movement description
during gait.
∗ To validate the developed strategy.
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• Work package 1: To build a dataset of eye movement for PD and control
patients during gait
– Methodology
∗ To perform a literature review to establish the better devices and conditions
for the recording of eye movement during gait.
∗ To perform some test recording and evaluate its results.
– Activities
1. To establish device for recording eye movement and conditions of capture
during gait in a semi-controlled environment.
2. To evaluate with test subjects to prove and design adequate condition of
recording.
3. To measure the quality of videos in order to determine if it is appropriate to
perform eye movement analysis.
4. To perform evaluations on control subjects and subjects with Parkinson’s
Disease.
– Analysis and strategies of risk mitigation
∗ Risk 1: Loss of dataset.
· Plan A: Save the information in backup storage devices.
· Plan B: Call back the patients for a new recording.
∗ Risk 2: The video don’t have optimal condition.
· Plan A: Establish errors in test.
– Project Deliverables
∗ Data set of eye movement during gait.
• Work package 2: To develop a strategy to characterize the eye movements
during gait.
– Methodology
∗ To characterize the eye normal and abnormal movement during gait in PD
for select moves to evaluate.
∗ To design a strategy for eye movement description.
∗ To validate strategy of characterization of the eye movement during gait.
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– Activities
1. To develop the background of eye movement characterization.
2. To select and develop some strategies to characterize the eye movement during
gait.
3. To evaluate the performance of the selected strategies.
4. To compare the output data of the selected method with ground truth of eyes
movements during gait in PD and control subjects.
5. To develop a strategy for eye movement description based on the results on
the previous activity.
6. To validate the developed strategy.
– Analysis and strategies of risk mitigation
∗ Risk 1: The are not well known patterns to differentiate the eye movement
during gait for control and PD patients in the literature.
· Plan A: Analyze the eye movement during gait, in presence of visual
cues whose response is well known, and establish the difference between
normal and pathological subject.
· Plan B: Analyze only the eye movements who are most commonly af-
fected in PD.
∗ Risk 2: The selected strategy performs poorly on the created dataset.
· Plan A: Pre-process images in order to enhance relevant features on the
dataset.
· Plan B: Record once again the data set.
– Project Deliverables
∗ Article of first approximation about strategies for eye movement description.
∗ Implementations of strategies for eye movement description.
∗ Validation of eye movement descriptor.
• Work package 3: To classify subjects with PD by stages based on eye move-
ment description during gait.
– Methodology
∗ To determinate a classical methods for diagnosis and classification of PD.
∗ To develop a classification of subjects with PD.
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– Activities
1. To establish the main methods for diagnosis and classification stage in PD .
2. To develop and implement a strategy to relate eye characterization data and
the stage of subjects with PD.
3. To classify subjects of our dataset with PD.
– Analysis and strategies of risk mitigation
1. Risk 1: The strategy can not properly classify the stage of subjects with PD.
∗ Plan A: Inspect the eye movement characterization.
∗ Plan B: Search for mistakes in the developed strategy.
– Project Deliverables
∗ Classification of Subjects with Parkinson’s Disease.
• Work package 4: To validate the developed strategy.
– Methodology
∗ To determine accuracy of the proposed classification method.
∗ To compare our strategy with others proposed in the literature.
– Activities
1. To apply the strategy selected classification on dataset.
2. To evaluate the performance using precision and recall.
3. To determinate statistical significance.
4. To compare the strategy with state of the art.
– Analysis and strategies of risk mitigation
∗ Risk 1: Poor statistical significance, precision or recall.
· Plan A: Adjust parameters of the method.
· Plan B: Check the measurements.
∗ Risk 2: The project is not completed within the time set.
· Plan A: Planning a new schedule for activities to be performed.
· Plan B: Perform multiple tasks simultaneously.
– Project Deliverables
∗ Validated method of Stage PD Recognition
∗ Thesis Document
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The main contribution of this thesis was characterization eye movement during gait that may
be used to diagnose and classify PD. Were developed two strategies to characterize ocular
movement. First, an automatic tracking strategy, that allow to know x and y eye position
during gait. Second, based in the optical flow calculation, whit this information was created
a histogram movement descriptor, to visualize and summarize to where subjects move the
eye during a gait cycle. These strategies are described below.
3 Characterizing the eye trajectory
during the gait towards Parkinson
stage identification
Presented on the “10th International Symposium on Medical Information Processing and
Analysis” SIPAIM 2014, October 2014
Parkinson’s Disease characterization is commonly carried out by measuring a motor abnor-
mality that may affect an optimal locomotion. However, such gait characterization is far from
achieving accurate and sensible early detection of this disease, dealying between 6 months to
3 years a first diagnosis. Current research has identified the eye movements (EM) as a pow-
erful biomarker that may detect and identify PD, even in early stages. However, this eye
analysis is now performed under fully controlled conditions and strict protocols, for which the
patient must follow a set of routine movements in a static position. Such protocols however
loss some natural eye movements during the gait that may help to promptly highlight the
disease. This work presents preliminary results characterizing and analyzing the center of
mass of the eye movement during the gait, captured using a high speed camera. An automatic
tracking strategy was herein implemented to follow the eye during the locomotion. Promising
results were obtained from a set of real patients diagnosed with Parkinson Diseases in stages
of 1 y 3, which show strong differences among the computed signals.
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3.1 Introduction
Parkinson’s Disease is the second most common neurodegenerative disease ( around 6.3
million people are affected worldwide), that progressively alters the motor patterns [1]. PD
is typically diagnosed and followed by using a standard gait motor characterization that
mainly measures the level of rigidity, tremor at rest and postural instability [27]. However,
such examination remains limited because of the diffuse border among normal and early PD
stages. Eye movement characterization has demonstrated high sensitivity to PD classifica-
tion and following up. Experimental evidence has demonstrated changes in the frequency
and amplitude of the eye movement that correlates with neurotransmitter deficiency and
abnormal motor movements [3, 8, 12]. The eye motion plays an important role during loco-
motion because visual exploration fully determined an optimal postural control. In early PD
stages, the abnormal visual motion may cause global motor alterations, loss of balance and
proprioceptive deficits [18, 24]. Such eye movement analysis has been carried out under many
restrictions, for instance the evaluation is performed in static position, under controlled con-
ditions and executing predetermined routines to the eye motion [65, 22]. These conditions
result highly restrictive, losing the characterization of natural eye gestures during a daily
exploration. Interestingly, the eye exploration motion correlates with the postural control
w.r.t external perturbations. In addition, the signals obtained from electro-oculography are
highly noisy, in particular those that correlate the eye movement with the corneo-retinal
standing potential [54]. The main contribution of this work is a preliminary eye motion
analysis of patients diagnosed with Parkinson in stages of 1.5, 3 and control patients. A
set of videos of patients during the locomotion were captured using a high speed camera
and an automatic tracking strategy was implemented to follow the eyes trajectory. Results
demonstrate a high sensitivity to discriminate normal and pathological eye motion patterns.
3.2 Methods
The herein presented analysis of the eye motion uses an automatic tracking strategy to follow
the eyes of patients during walking ( An example of tracking is shown in Figure 3-1) . In next
subsections the methodology is presented. Then, images were mapped to a feature space
using a set of Haar functions, thereby describing a set of rectangular features at the different
scales that can be learned and used as rectangular detectors, in particular to characterize
the eye. Finally an adapted adaboost learning algorithm allows to weight the features more
representative in the eye identification task [60].
3.2.1 Tracking the Eyes
Given a new video-sequence, the eyes were identified at each frame by mapping the image
to the Haar space and these features used by a cascade adaboost classifier. Such cascade
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classifier allows a fast identification of the eyes, taking in average less than one millisecond
to perform such task. Nevertheless, tracking errors were observed in some frames because
of uncontrolled reference point. Every patient signed an informed consent according to the
Helsinki declaration.
3.2.2 Experimental setup
The proposed approach was tested using a real dataset of patients recorded with a custom
constructed tracking system (see in Figure 3-1(b)). A total of 8 participants were recorded
distributed as: 4 parkinson disease patients (stages of 1.5 and 3) and 4 controls. A light
high speed camera Gopro+3 on helmet ( 840 x 480, 240 fps ) was used to capture the eye
movements while the patient was walking along of a platform of 4.50m.
Figure 3-1: Left panels (a) show different captured videos. Panel (b) displays a patient
walking with the custom tracking system. Right panels (c) exhibit the eyes
tracked during a typical sequence.
3.2.3 Learning Eyes features
A Viola and Jones tracking strategy was herein implemented to follow the eyes of patients
during locomotion [61]. For doing so, a training step was firstly performed from a bank
of positive (images with eyes) and negative images. Each image was then represented as
an integral image to rapidly calculate rectangular characteristics of the image at multiple
scales, filtering out some noise high frequencies and allowing a rapid identification of the
interest zone. For each video the proposed strategy computed the global CoM trajectory
of the eyes during a free walking (without fixation point), allowing to capture the natural
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eye movement when exploring the scene. Figure 3-2 shows a typical trajectory obtained by
control patients. A relative constant motion is observed in these participants. The notorious
amplitude change on eye trajectories is may be attributed with specific gait torques such as
the heel-strike, which alter the body dynamic, producing many times jumps that modify the
motion .
3.3 Results
For each video the proposed strategy computed the global CoM trajectory of the eyes during
a free walking (without fixation point), allowing to capture the natural eye movement when
exploring the scene. Figure 3-2 shows a typical trajectory obtained by control patients. A
relative constant motion is observed in these participants. The notorious amplitude change
on eye trajectories is fully correlated with specific gait torques such as the heel-strike.
Figure 3-2: Eye movements in axis x to the left and y to the right of control subject
In Figure 3-3, a typical PD trajectory is presented, a patient diagnosed in stage 1.5. In
spite of the low change in terms of the global motion, the eye trajectory evidences strong
changes regarding the visual exploration. The x, y-axes totally lost the amplitude change
that suggests low exploration of the eye and motion rigidity.
In Figure 3-4, a pattern, observed in a patient with PD in stage 3, is plotted. A total
abnormal eye pattern is reported. While in y−axis a very smooth motion was reported,
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Figure 3-3: Eye movements in axis x to the left and y to the right of PD stage 1.5
without any exploration. In the x−axis an altered motion is reported that is associated to
the response of gait torques with poor stabilization and therefore postural alterations.
This behaviour contrasts with control subjects (Figure 3-2.) who keep a constant motion this
have a relationship with normal visual scanning that is done when walk, this exploration
or EM is necessary for appropriate postural control, being that in free walking (without
fixation point), visual system scans the body and compare with environment for do postural
adjustments during gait, this ability will be affected in PD because, low scanning or EM
generating postural alterations and abnormal movement when the subject walking.
Finally in Figure 3-5, it was summarized the trajectory of the center of mass for each each
patient in x and y axis (left and right panel respectively). As is illustrated in each box-plot,
the CoM displacement is discriminant enough among the different patients being a powerful
biomarker for parkinson disease. Large variability is shown in boxplot corresponding to a
patient diagnosed with parkinson in level three. Such large variability is associated to the
deficiency on eye motion control.
3.4 Conclusions
In this paper an eye motion analysis of parkinsonian and control patients during walking
was presented. Preliminary results show important changes in frequency and amplitude of
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Figure 3-4: Eye movements in axis x to the left and y to the right of PD stage 3
.
Figure 3-5: Statistical box-plot representation of three different displacement for control
and parkinson diseases. The right and left panel represent the x and y axis
respectively. The right boxplot summarizes the movement for 5 control patients
while the middle boxplot represent a displacement for a 1.5 parkinson disease
patient. Finally in the left boxplot is illustrated the statistical boxplot for a
parkinson patient diagnosed with stage of 3.
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CoM eye trajectory in PD patients. The more advanced the stage of the disease, the more
important the observed alterations, suggesting this analysis is a potential tool to support
the PD diagnosis. Future works include the evaluation of the proposed approach in larger
datasets.
4 A Characterization of the Parkinson’s
Disease by describing the Visual Field
motion During Gait
Presented on the “11th International Symposium on Medical Information Processing and
Analysis” SIPAIM 2015, November 2015
An early diagnosis of Parkinson’s Disease (PD) is crucial towards devising successful re-
habilitation programs. Typically, the PD diagnosis is performed by characterizing typical
symptoms, namely bradykinesia, rigidity, tremor, postural instability or freezing gait. How-
ever, traditional examination tests are usually incapable of detecting slight motor changes,
specially for early stages of the pathology. Recently, eye movement abnormalities have cor-
related with early onset of some neurodegenerative disorders. This work introduces an new
characterization of the Parkinson disease by describing the ocular motion during a common
daily activity as the gait. This paper proposes a fully automatic eye motion analysis using
a dense optical flow that tracks the ocular direction. The eye motion is then summarized
using orientation histograms constructed during a whole gait cycle. The proposed approach
was evaluated by measuring the χ2 distance between the orientation histograms, showing
substantial differences between control and PD patients.
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4.1 Introduction
Among the neuro-degenerative disorders, PD is a major public health concern, with about
10 million people worldwide in 2005 and the expectation that this figure will be doubled
for 2030, according to the World Health Organization (WHO) [40]. Typically, this pathol-
ogy is associated to symptoms such as bradykinesia, rigidity, tremor, postural instability,
freezing gait (FOG) and other gait disorders [56, 9]. However, traditional tests are not sen-
sitive enough and may delay the diagnosis between 6 months to 3 years [27, 44], among
others because of the high inter and intra-examiner variability. Some investigations have
then focused in other more unspecific symptoms, such as depression, dementia or smell and
sleep disorders[15], aiming to improve the disease characterization by examining upper brain
functions that might be affected. Lately, eye movement abnormalities have been studied and
characterized as strong biomarkers of Parkinson’s Disease [3], following the hypothesis that
this disease affects the dopamine neural systems [36].
The oculo-motor control centers are highly sensitive to dopamine deficiency, a condition re-
flected in the eye motion dysfunction that seriously impairs the eye response to the target
spatial location, even for early stages of the PD [18, 57]. It has been demonstrated that eye
motor function correlates with the disease stage [46, 24]. However, the detection of some
degree of motion abnormality is still insufficient and any characterization of the PD demands
in addition a precise quantification. Usually, customized devices track the eye movement by
measuring potential differences when the eye targets a particular object, but these measures
are noisy and usually confuse the eye with other salient face regions. Overall, these tests
under controlled conditions hide the natural eye motion control. Consequently, any motion
evaluation should be performed in conditions that respect the natural eye movement [54].
The gait particularly constitutes a state in which all systems connect together for the inter-
action with the environment is optimal. During gait, the eye constantly explores the world
to feedback every system about the surrounding conditions. The idea of measuring the eye
movement during different gait tasks becomes then appealing in terms of registering the
ocular activity in natural conditions [66].
A main contribution of this work is the characterization of the Parkinson Disease by deter-
mining the ocular motion patterns during gait. The proposed approach performs a classical
dense optical flow description that captures the instantaneous eye motion, upon which a ve-
locity orientation histogram is built. The relative occurrence of the flow vectors is computed
for a pre-defined set of orientations. Significant differences were thus found between control
and PD patients, and also among the different stages of the disease. The rest of the paper
is structured as follows, the dataset and video recording conditions are described in section
4.2.3, the eye motion tracking and the histogram construction are explained in sections 4.2.1
and 4.2.2 respectively. Section 4.3 shows the results by comparing eye movement description
in control and PD subjects.
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Figure 4-1: Panel a shows the patient and the capture system. Panel b displays the optical
flow calculation over the entire image and the RoI selection. Panel c depicts
the velocity orientation histogram.
4.2 Proposed approach
Dopaminergic brain systems play a crucial role in motor and cognitive mechanisms as well as
a number of basic lower-level functions including lactation, sexual gratification, and nausea.
Under the assumption that control eye abnormalities are related with dopamine deficiency, a
motion eye descriptor during gait is herein introduced to characterize the Parkinson disease.
The proposed approach starts by characterizing the instantaneous eye movement using a
dense optical flow field from a local appearance matching between consecutive frames. Af-
terwards, the eye movement is coded for a complete gait cycle as a histogram of orientations
previously selected. A further description of each step is presented hereafter.
4.2.1 Dense optical flow
The eye motion was captured with a camera attached to a helm placed on the forehead
(see Figure 4-1(a)). The presence of particular salients in the face like the zygomatic arch
may hamper proper tracking and eye detection [54], a common problem for traditional eye
detection methods like the electrooculography or some video processing techniques like the
background subtraction. An appropriate characterization of this eye movement was then
herein performed by capturing apparent motion patterns of objects representing local pixel
motion between two consecutive frames. The dense optical flow approach proposed by Horn
and Schunck [23, 63, 31] was then implemented and computed for consecutive frames and
the obtained apparent motion ends up by following an oriented pixel-to-pixel and neighbor
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variation, case in which flow distortions are minimal and the smoothest solutions can be
selected. This process is of course iterative. One of the main advantages of this method is
that it produces a high density of flow vectors, i.e. the missing information in the inner parts
of homogeneous objects is completed by the motion boundaries and the tracking results very
robust to a many types of noised [39]. For the proposed approach, the Parkinson Disease
characterization was achieved by this classical algorithm, describing directional changes for
each pixel along the time and thereby determining how eyes move when the subject is walk-
ing, as illustrated in 4-1(b).
4.2.2 Orientation flow histograms
Exploration eye movements are essential part of the human foveated visual system that pur-
suits and gazes objects of interest by integrating information from many sources. The whole
visual task must afford the eye reaches both an angular velocity that minimizes the retinal
slip and a gentle movement that effectively reduces the targeted offset of the image. This
pursuit system is forced if the subject is walking and the background is variable, as pro-
posed in the present investigation but then the descriptor should obtain information about
the velocity and the targeted position. Yet this is nearly impossible with no information
about the background, it is possible however an estimate if the two experimental groups are
evaluated under the same conditions. In consequence, a representative descriptor per class is
constructed as an orientation flow histogram for the whole gait cycle, thereby correlating the
directional eye movements computed from the optical flow. This orientation flow histogram
summarizes the eye patterns from multiple directions by computing the instantaneous eye
motion during a gait cycle [14]. The histogram in this work was computed from the opti-
cal flow information inside a region of interest (RoI), where the left eye was used to define
the RoI, since the camera recording was focused on this eye. Specifically, this histogram
Ht(i) = [ht(i1), ht(i2)...., ht(in)] is composed of 36 bins homogeneously distributed (see 4-
1(c)). Finally, the Chi-squared distance χ2 was calculated between histograms to evaluate
the discrimination capability of the proposed approach.
4.2.3 Data Acquisition
Twelve control subject and seven subject with Parkinson’s Disease participated in this study
in the gait laboratory of Universidad Nacional de Colombia. The experimental group of PD
patients are distributed as: 1 PD subject in stage 1, 3 PD subjects in stage 2 and 3 PD
subjects in stage 3, according to Hoehn and Yahr scale (1 corresponds to the earliest PD
stage and 5 stands for the most advanced stage of the pathology)[30]. The data set was
acquired by a high speed camera GoPro HERO3+, attached to a helmet (840×480, 240fps)
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placed at the forehead. Eye movement was acquired while the subjects were walking along
a customized walkway of 4.50m, with no specific request of the experimenter for fixating at
any point, this experimental setup is shown in 4-1. Each patient agreed to be recorded and
a written informed consent was provided and signed, following the Helsinki declaration.
4.3 Results
In this work, it was analyzed the ocular motion during gait, a common daily activity. Con-
stant changes in the environment forces the organ to scan and re-configure the whole motor
system[42]. This analysis allows a proper PD characterization. The set of motion histograms
was computed per subject and during a single gait cycle. Additionally, a mean histogram
for each available class estimates the eye pattern per class (see Figure 4-2) and allows the
comparisons between classes.
Figure 4-2(a) displays the expected ocular movement for control patients, a dominant direc-
tion while the patient is exploring the visual space during gait. This sensing is required to
measure and planning the movement, provided that a suitable visual feedback during gait.
In this case, subjects walk the motion lab pathway [42, 29, 21].
The orientation histogram for the single patient with a Parkinson’s disease stage 1, is shown
in Figure 4-2(b). This histogram illustrates the early impairment by the motion amplitude
and symmetry patterns.
On the other hand, Figures 4-2(c) and 4-2(d) show in general, that as long as the Parkinson’s
disease advances, the patient movement requires more effort to select the correct gazing, and
the system then evidences an eye sweeping almost every direction. Specifically, Figure 4-2(c)
illustrates the imprecise gaze with the consequent increment in the number of directions that
a patient explores. Furthermore, in Figure 4-2(d), eye motion changes are notorious, the
exploration direction is modified.
The Chi-squared distance quantifies the level of similarity between histograms. The present
study has determined differences between control and PD subjects and along the different
PD stages. Furthermore, this metric provides a discriminating measurement and description
of the ocular motion. Table 1 shows the compared Histogram Mean per class or stage (in
the column) for each subject of the class, while also the mean of this comparison is shown.
Results in Table 1 evidences differences between control subjects and PD patients. More-
over, these measurements show how the distance between histograms increases with respect
to normal subjects as long as the the PD stage advances, i.e. these results demonstrate
this approach is capable of distinguishing between normal subjects and PD stages and the
presented describer characterizes the early stages of the PD [58].
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Table 4-1: Chi-Square, Perfect match is 0 and total mismatch is unbounded. HM is His-
togram Mean. Only in one case a single histogram is used because this class has
only one patient. N is Control. PD1 is Parkinson’s Disease Stage 1. PD2 is
Parkinson’s Disease Stage 2. PD3 is Parkinson’s Disease Stage 3.
N-M PD1 PD2-M PD3-M
HM-N 0.09 0.06 0.19 0.21
H-PD1 0.15 0 0.3 0.3
HM-PD2 0.19 0.23 0.09 0.12
HM-PD3 0.24 0.25 0.15 0.08
4.4 Conclusion
In this paper has introduced a novel ocular motion feature characterizes PD, even in early
stages. Orientation flow histograms are used as representative descriptors per class. This
characterization is performed in natural conditions using a robust eye movement descriptor.
This approach detects different stages of the disease. Future work includes a more exhaustive
experimentation, the method will be performed with a larger data set.
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(a) Normal Histogram-Mean. (b) PD1 Histograms.
(c) PD2 Histograms-Mean. (d) PD3 Histograms-Mean.
Figure 4-2: The histogram (a) shows the typical movement directions in control subjects.
The histogram (b) illustrates the eye movement performance in Parkinson’s
disease stage 1 (PD1). The histogram (c) displays eye movement in Parkinson’s
disease stage 2 (PD2) and finally, in (d) it is illustrated the histogram that shows
the impairment in Parkinson’s disease stage 3 (PD3)
5 Conclusions and Perspectives
This thesis presented two different methodological proposals to characterize the main eye
motion patterns during the gait pattern. These approaches are based on the automatic
characterization of video-sequences by registering the ocular movement. The proposed ap-
proaches were evaluated for different population of patients that include control and PD
subjects at different levels of the disease. The descriptors computed from the proposed ap-
proaches, evidenced significant differences among the group of patients. The results shown
that the increasing dispersion of eye movements or loss of orientation are determinant to
establish the disease progression. Subsequently, the proposed strategy is useful to support
the diagnosis of the PD.
In a future work, include an exhaustive evaluation with larger population of patients. As
well as, the proposition of new markerless approach to better understand the complex ocular
motion patterns.
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rina ; Gräber, Stefan ; Massing, Christoph ; Spiegel, Jörg ; Behnke, Stefanie
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